Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries

Tsaban, Gal; Barrett, Orit; Peles, Ido; Abramowitz, Yigal; Shmueli, Hezzy; Alnsasra, Hilmi; Cafri, Carlos; Zahger, Doron; Koifman, Edward

doi:10.1016/j.atherosclerosis.2023.01.005

Cited by 4 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some patients may have no appreciable coronary artery narrowing, and others may have considerable disease not meeting the criteria for obstructive disease (<50% stenosis). In a 2023 paper in the journal Atherosclerosis by Tsaban et al, the authors found that non-obstructive coronary atherosclerosis is associated with worse outcomes in MINOCA versus patients with no evident atherosclerotic plaques [ 14 ]. Coronary vascular dysfunction, both at the microvasculature and epicardial level, is one of the possible causes of MINOCA presentation.…”

Section: Reviewmentioning

confidence: 99%

MINOCA: A Working Diagnosis

Rodríguez Candelario,

Perez-Aybar,

Roman-Ramos

2023

Cureus

View full text Add to dashboard Cite

Cases of patients presenting with myocardial infarction (MI) without angiographic obstructive CAD are not trivial and have significant prevalence. "The Fourth Universal Definition of MI" (4UDMI) published in 2018 introduced MI with non-obstructive coronary arteries (MINOCA). The new section was of great importance as it validated the diagnosis by defining its criteria and recognizing its presence in the community and the need for further investigation. Given the nature of the diagnosis of MINOCA, coronary angiography provides limited information about prognosis and risk stratification for future major adverse cardiovascular events (MACE). Thus, additional imaging to understand the underlying etiology of MINOCA in conjunction with a better understanding of prognostic factors is necessary to expand on the current guidelines and aid in screening for possible complications, risk of MACE, and all-cause mortality. Discerning the etiology of the presentation is crucial, and physiologic studies, as well as additional imaging, are an important part of this evaluation. These modalities include intravascular studies such as optical coherence tomography (OCT), intravascular ultrasound (IVUS), fractional flow reserve (FFR), and imaging in the form of cardiac CT (CCT) and cardiac MRI (CMR). This step is essential to target treatment regimens more efficiently. The purpose of promoting multiple imaging modalities beyond traditional angiography is to address the working MINOCA diagnosis, with the finality of identifying the specific ischemic pathophysiology. MINOCA has multiple causative mechanisms, making it a heterogeneous collection of etiologies, resulting in acute MI: atherosclerotic, and non-atherosclerotic. This literature revision demonstrates that MINOCA prevalence and mortality are not trivial, and the diagnosis affects quality of life. MINOCA presents a definitive risk of MACE without proper stratification and targeted medical therapy. Several prognostic factors of morbidity and mortality in MI-CAD patients have been identified to correlate with MINOCA patients, especially inflammatory markers. MINOCA is not an exclusion diagnosis but a working diagnosis for which further imaging studies should be performed.

show abstract

Section: Reviewmentioning

confidence: 99%